Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct-Dec;15(4):377-382.
doi: 10.4103/sja.SJA_87_20. Epub 2021 Apr 8.

Assessment of pain in patients with primary immune deficiency

Affiliations

Assessment of pain in patients with primary immune deficiency

Maram Al Banyan et al. Saudi J Anaesth. 2021 Oct-Dec.

Abstract

Background: Primary immune deficiency (PID) patients may develop acute or chronic pain. Pain has not been studied in this population until now.

Objectives: This study systematically assessed the pain of various durations in PID patients using validated pain questionnaires.

Subjects and methods: A Short-Form McGill Pain Questionnaire (SF-MPQ), already validated in the Arabic language, was used to ascertain the characteristics and severity of pain. Additionally, an Arabic version of the Neuropathic Pain Questionnaire-Short Form (NPQ-SF) was employed to evaluate neuropathic pain in the same group of patients.

Results: Forty-six patients participated in the study. The mean age of the patients was 25 years. The most commonly diagnosed PID was a common variable immune deficiency (32.6%), followed by severe combined immune deficiency (19.57%). Based on the SF-MPQ, the pain was experienced by 30.4 % of the subjects who participated in the study; 57% of whom were on regular pain medications. The most common site reported for pain was the abdomen (35.7%). The mean duration of pain was 36.1 days ± 34.6 days. The most common comorbidities in these patients were bronchiectasis, followed by immune thrombocytopenic purpura, and scoliosis. None of the PID patients had significant neuropathic pain based on NFQ-SF.

Conclusion: To the best of our knowledge, this is the first study to assess the prevalence as well as the severity and duration of pain in PID patients. There were significantly more subjects who had continuous pain. Treatment of pain in PID patients will have a significant effect on improving their quality of life.

Keywords: Pain; primary immune deficiency; validated questionnaires.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Majlesi J. Patients with chronic musculoskeletal pain of 3-6-month duration already have low levels of health-related quality of life and physical activity. Curr Pain Headache Rep. 2019;23:81. - PubMed
    1. Newshan G. Pain in human immunodeficiency virus disease. Semin Oncol Nurs. 1997;13:36–41. - PubMed
    1. Totsch SK, Sorge RE. Immune system involvement in specific pain conditions. Mol Pain. 2017;13:1744806917724559. - PMC - PubMed
    1. Mellouli F, Mustapha IB, Khaled MB, Besbes H, Ouederni M, Mekki N, et al. Report of the Tunisian registry of primary immunodeficiencies: 25-years of experience (1988-2012) J Clin Immunol. 2015;35:745–53. - PubMed
    1. Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38:96–128. - PMC - PubMed